Sign In
Buy TKNO
$5.13
-0.0500 (-0.97%)
At Close: Jun 03, 2026
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
08:00am, Thursday, 26'th Oct 2023
Teknova today announced that the Company will report its financial results for the third quarter on Thursday, November 9, 2023, following close of market.
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
08:00am, Wednesday, 27'th Sep 2023
Novel AEX screening kit – now available for AAV6 – and an expansive suite of high-quality reagents designed to expedite plasmid production will help accelerate breakthroughs across multiple AAV co
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
04:01pm, Tuesday, 19'th Sep 2023
HOLLISTER, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization o
Alpha Teknova, Inc. (TKNO) Q2 2023 Earnings Call Transcript
09:20am, Sunday, 13'th Aug 2023
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2023 Earnings Conference Call August 10, 2023 5:30 PM ET Company Participants Sara Michelmore - MacDougall Advisors Stephen Gunstream - President & Chief Executiv
Teknova Reports Second Quarter 2023 Financial Results
04:01pm, Thursday, 10'th Aug 2023
Second quarter 2023 total revenue was $11.5 million, up 26% sequentially Received certification of new state-of-the-art facility for production of GMP-grade products Company revises 2023 revenue guida
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
08:00am, Wednesday, 09'th Aug 2023
State-of-the-art facility in Hollister, California is designed to help bioprocessing and gene therapy companies scale from research to clinical production State-of-the-art facility in Hollister, Calif
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
08:00am, Wednesday, 26'th Jul 2023
HOLLISTER, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization o
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
08:00am, Tuesday, 11'th Jul 2023
First-of-its-kind screening kit now available for AAV8 – along with a suite of high-quality reagents to support the entire AAV workflow – helping gene therapy developers save months in process dev
Teknova to Participate in Upcoming Investor Conference
08:00am, Thursday, 25'th May 2023
HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercial
Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript
01:57pm, Saturday, 13'th May 2023
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2023 Earnings Conference Call May 10, 2023 5:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chi
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
08:00am, Wednesday, 10'th May 2023
Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks Company will share their latest findings for custom product innov
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
08:00am, Wednesday, 26'th Apr 2023
HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commerci
Down -48.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Teknova (TKNO)
10:42am, Friday, 07'th Apr 2023
Alpha Teknova (TKNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revi
Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript
08:04pm, Wednesday, 15'th Mar 2023
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2022 Results Conference Call March 15, 2023 5:00 PM ET Company Participants Jen Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief E
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)
08:02am, Tuesday, 14'th Mar 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
